The hypothalamic-pituitary-adrenal axis in critical illness

Area of Science:

• Endocrinology
• Critical Care Medicine
• Immunology

Background:

• The hypothalamic-pituitary-adrenal (HPA) axis regulates homeostasis, interacting with endocrine, neural, and immune systems.
• Cortisol, a key glucocorticoid, exerts effects via the glucocorticoid receptor (GR).
• Glucocorticoids possess potent anti-inflammatory properties, leading to their use in critical illness.

Purpose of the Study:

• To address the challenges in diagnosing adrenal insufficiency and guiding glucocorticoid therapy in critically ill patients.
• To highlight the need for improved methods to assess glucocorticoid action and GR function.

Main Methods:

• Review of existing literature on HPA axis function, glucocorticoid use, and adrenal insufficiency in critical care.
• Discussion of limitations in current diagnostic criteria and patient heterogeneity.
• Emphasis on the need for cellular-level assessment of glucocorticoid action.

Main Results:

• Early studies suggested glucocorticoids were ineffective or harmful in critical illness.
• Recent concepts propose relative adrenal insufficiency or acquired glucocorticoid resistance in critically ill patients.
• Inconsistent diagnostic criteria and patient variability hinder definitive conclusions on glucocorticoid efficacy.

Conclusions:

• Diagnosing adrenal insufficiency in critically ill patients remains a significant clinical challenge.
• Current evidence is insufficient to establish definitive guidelines for glucocorticoid use.
• Development of physiologically relevant tools to assess cellular-level glucocorticoid action and GR function is essential.